Yet with most COVID cases in the U.S. currently caused by fast-spreading Omicron, a new coronavirus variant with mutations in the part of SARS-CoV-2 targeted by monoclonals, “there’s only one [antibody] that actually works,” says Michelle Barron, a professor of medicine at the University of Colorado School of Medicine and senior medical director of infection prevention and control at the nonprofit health system UCHealth.